Shares Outstanding Shares Outstanding n/a Close	47.56M
Shares Change (YoY) Shares Change (YoY) n/a Close	2.02%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	1.32%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	99.99%
Shares Floating Shares Floating n/a Close	45.62M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	761
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.13%

Short Selling Information

The latest short interest is 4.68M, so 9.85% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	4.68M
Short % of Shares Out Short % of Shares Out n/a Close	9.85%
Short % of Float Short % of Float n/a Close	14.54%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	9.86

Valuation Ratios

The PE ratio is -59.25 and the forward PE ratio is 244.44. BioLife Solutions's PEG ratio is 0.83.

PE Ratio PE Ratio n/a Close	-59.25
Forward PE Forward PE n/a Close	244.44
PS Ratio PS Ratio n/a Close	14.54
Forward PS Forward PS n/a Close	5.1
PB Ratio PB Ratio n/a Close	3.43
P/FCF Ratio P/FCF Ratio n/a Close	229.8
PEG Ratio PEG Ratio n/a Close	0.83

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioLife Solutions.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.09.

Current Ratio Current Ratio n/a Close	4.54
Quick Ratio Quick Ratio n/a Close	3.66
Debt / Equity Debt / Equity n/a Close	0.09
Debt / EBITDA Debt / EBITDA n/a Close	19.7
Debt / FCF Debt / FCF n/a Close	5.8
Interest Coverage Interest Coverage n/a Close	-9.92

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$517,320.75
Profits Per Employee Profits Per Employee n/a Close	$-126,943.4
Employee Count Employee Count n/a Close	159
Asset Turnover Asset Turnover n/a Close	0.21
Inventory Turnover Inventory Turnover n/a Close	0.84

Taxes

Income Tax Income Tax n/a Close	-38K
Effective Tax Rate Effective Tax Rate n/a Close	0.33%

Stock Price Statistics

The stock price has increased by 9.93% in the last 52 weeks. The beta is 1.82, so BioLife Solutions's price volatility has been higher than the market average.

Beta Beta n/a Close	1.82
52-Week Price Change 52-Week Price Change n/a Close	9.93%
50-Day Moving Average 50-Day Moving Average n/a Close	22.7
200-Day Moving Average 200-Day Moving Average n/a Close	24.71
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	47.31
Average Volume (20 Days) Average Volume (20 Days) n/a Close	581,707

Income Statement

In the last 12 months, BioLife Solutions had revenue of 82.25M and earned -20.18M in profits. Earnings per share was -0.44.

Revenue Revenue n/a Close	82.25M
Gross Profit Gross Profit n/a Close	57.75M
Operating Income Operating Income n/a Close	-7.13M
Net Income Net Income n/a Close	-20.18M
EBITDA EBITDA n/a Close	1.53M
EBIT EBIT n/a Close	-7.13M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-0.44

Full Income Statement

Balance Sheet

The company has 95.39M in cash and 30.17M in debt, giving a net cash position of 65.21M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	95.39M
Total Debt Total Debt n/a Close	30.17M
Net Cash Net Cash n/a Close	65.21M
Retained Earnings Retained Earnings n/a Close	-335.1M
Total Assets Total Assets n/a Close	395.14M
Working Capital Working Capital n/a Close	103.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.43M and capital expenditures -3.23M, giving a free cash flow of 5.2M.

Operating Cash Flow Operating Cash Flow n/a Close	8.43M
Capital Expenditures Capital Expenditures n/a Close	-3.23M
Free Cash Flow Free Cash Flow n/a Close	5.2M
FCF Per Share FCF Per Share n/a Close	0.11

Full Cash Flow Statement

Margins

Gross margin is 70.21%, with operating and profit margins of -8.67% and -24.54%.

Gross Margin Gross Margin n/a Close	70.21%
Operating Margin Operating Margin n/a Close	-8.67%
Pretax Margin Pretax Margin n/a Close	-13.89%
Profit Margin Profit Margin n/a Close	-24.54%
EBITDA Margin EBITDA Margin n/a Close	1.86%
EBIT Margin EBIT Margin n/a Close	-8.67%
FCF Margin FCF Margin n/a Close	6.33%

Dividends & Yields

BLFS does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for BLFS is $31, which is 39.3% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$31
Price Target Difference Price Target Difference n/a Close	39.3%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	7

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Jan 29, 2014. It was a backward split with a ratio of 1:14.

Last Split Date Last Split Date n/a Close	Jan 29, 2014
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:14

Scores

Altman Z-Score Altman Z-Score n/a Close	14.29
Piotroski F-Score Piotroski F-Score n/a Close	5